NP

Nikita Prasad Gugale

Active Director Designated Partner DIN 11120814
DIN 11120814 First appointment May 2025 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Nikita Prasad Gugale

Data last updated:

Nikita Prasad Gugale is a Designated Partner at Aikyaam Biopharma Llp (since 2025). The company operates in Biotechnology.

DIN 11120814
Primary Designation Designated Partner
Industry Biotechnology
First Appointment 22 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner22 May 20252025Active

Board colleagues of Nikita Prasad Gugale

NameDINCompanyDesignation
Priya Bharat Dholu10946451Aikyaam Biopharma LlpDesignated Partner
Sayali Deven Metha10022283Aikyaam Biopharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Aikyaam Biopharma Llp
Premium access

Shareholding and investment profile for Nikita Prasad Gugale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikita Prasad Gugale

Nikita Prasad Gugale currently holds 1 directorship: Aikyaam Biopharma Llp (Designated Partner, since 22 May 2025).

Nikita Prasad Gugale was first appointed on 22 May 2025 as Designated Partner at Aikyaam Biopharma Llp.

The current boards of Nikita Prasad Gugale's companies include Priya Bharat Dholu (Aikyaam Biopharma Llp), Sayali Deven Metha (Aikyaam Biopharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available